169 related articles for article (PubMed ID: 12373297)
1. Evaluation of telomerase in the development and progression of colon cancer.
Boldrini L; Faviana P; Gisfredi S; Zucconi Y; Di Quirico D; Donati V; Berti P; Spisni R; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G
Int J Mol Med; 2002 Nov; 10(5):589-92. PubMed ID: 12373297
[TBL] [Abstract][Full Text] [Related]
2. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of telomerase mRNA (hTERT) in colon cancer.
Boldrini L; Faviana P; Gisfredi S; Zucconi Y; Di Quirico D; Donati V; Berti P; Spisni R; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G
Int J Oncol; 2002 Sep; 21(3):493-7. PubMed ID: 12168091
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and p53 gene mutation in familial polyposis coli.
Ikeguchi M; Makino M; Kaibara N
Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
[TBL] [Abstract][Full Text] [Related]
5. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
Tatsumoto N; Hiyama E; Murakami Y; Imamura Y; Shay JW; Matsuura Y; Yokoyama T
Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712
[TBL] [Abstract][Full Text] [Related]
6. Change in telomerase activity during human colorectal carcinogenesis.
Yoshida R; Kiyozuka Y; Ichiyoshi H; Senzaki H; Takada H; Hioki K; Tsubura A
Anticancer Res; 1999; 19(3B):2167-72. PubMed ID: 10472326
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.
Skelly MM; Troy A; Duffy MJ; Mulcahy HE; Duggan C; Connell TG; O'Donoghue DP; Sheahan K
Clin Cancer Res; 1997 Oct; 3(10):1837-40. PubMed ID: 9815571
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity associated with acquisition of malignancy in human colorectal cancer.
Chadeneau C; Hay K; Hirte HW; Gallinger S; Bacchetti S
Cancer Res; 1995 Jun; 55(12):2533-6. PubMed ID: 7780964
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity in different clinical staging of colorectal adenocarcinoma.
Lukman K; Maskoen AM; Achmad TH; Hanafi B; Karnadihardja W
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():491-7. PubMed ID: 10895200
[TBL] [Abstract][Full Text] [Related]
11. Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis.
Tang R; Cheng AJ; Wang JY; Wang TC
Cancer Res; 1998 Sep; 58(18):4052-4. PubMed ID: 9751608
[TBL] [Abstract][Full Text] [Related]
12. Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectal adenocarcinoma.
Jang SH; Min KW; Paik SS; Jang KS
J Clin Pathol; 2012 Aug; 65(8):735-9. PubMed ID: 22554968
[TBL] [Abstract][Full Text] [Related]
13. TGFbeta1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps.
Sparks R; Bigler J; Sibert JG; Potter JD; Yasui Y; Ulrich CM
Int J Epidemiol; 2004 Oct; 33(5):955-61. PubMed ID: 15020570
[TBL] [Abstract][Full Text] [Related]
14. Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
Fujita M; Tomita S; Fukui H; Ueda Y; Fujimori T
J Exp Clin Cancer Res; 1999 Mar; 18(1):119-24. PubMed ID: 10374691
[TBL] [Abstract][Full Text] [Related]
15. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
[TBL] [Abstract][Full Text] [Related]
16. [Telomerase activity in colorectal cancer--a semi-quantitative procedure].
Ohki S; Satoh H; Watanabe F; Andoh Y; Nomizu T; Yoshida T; Tsuchiya A; Abe R; Yamaki Y
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():469-74. PubMed ID: 9589055
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas.
de Bruin PA; Griffioen G; Verspaget HW; Verheijen JH; Lamers CB
Cancer Res; 1987 Sep; 47(17):4654-7. PubMed ID: 3621160
[TBL] [Abstract][Full Text] [Related]
18. Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer.
Balasubramani M; Day BW; Schoen RE; Getzenberg RH
Cancer Res; 2006 Jan; 66(2):763-9. PubMed ID: 16424007
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity and telomere length in the colorectal polyp-carcinoma sequence.
Valls Bautista C; Piñol Felis C; Reñé Espinet JM; Buenestado García J; Viñas Salas J
Rev Esp Enferm Dig; 2009 Mar; 101(3):179-86. PubMed ID: 19388798
[TBL] [Abstract][Full Text] [Related]
20. Polyps with different grades of dysplasia and their distribution in the colorectum.
Yamamoto M; Mine H; Kusumoto H; Maehara Y; Sugimachi K
Hepatogastroenterology; 2004; 51(55):121-3. PubMed ID: 15011845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
